Pharma's Market
SPECIAL REPORT
MOST SHARED
- Consumer Sentiment Falters, Despite Job Growth
- Bill Murray's View on the Economy
- Santelli's Morning Bond Report
- Videogame Sales Fell 34 Percent in January
- Steelers' Antonio Brown Spends Super Bowl Week with Twitter Fan Turned BFF
- Home of the Oscars Battles For Kodak Sponsorship
- Greek Police Union Wants to Arrest EU, IMF Officials
- Stocks Stumble as Greek Talks Stall; Vix Soars
- How to Date a Wall Street Man
- Bonus Question Dogs Barclays’ CEO Bob Diamond
- 5 Hedge Funds’ Top Stocks Soar After 2011 Rout
- This Valentine’s Day Love Is Served on a Silver Platter
- CEO to CEO: Our Roles Are Changing
- Clint Eastwood ‘Surprised’ by Reaction to Chrysler's ‘Halftime in America’ Ad
- Bulls Check In to Community Health
- Bank of America’s Worst-Case Scenario Gets More Real
- Tesla Unveils First SUV: Model X
- New York Fashion Week Hits the Runway as Colors Pop
- Mulling Buffett's Stock Advice? Get in With REITs: Fund Managers
- Greece Austerity Deal Runs Into Trouble Once Again
- Obama Exempts Religious Employers on Birth Control
- Bonus Bloodbath: Europe Banker Backlash Continues
- Diamond Investing: Why It's Not for the Faint of Heart
- SEC Reaches Settlement in Bear Stearns Fraud Case
- Israel Likely to Bomb Iran This Year: Political Analyst
- The World's Best Beers
- Rep. Bachus Faces Insider Trading Probe: Report
- Consumer Sentiment Falters, Despite Job Growth
RSS FEED
Lilly's Sex Survey: Will It Have Desired Effect On Cialis?
Reporter
![]() |
The study, paid for by Clialis-maker Eli Lilly [LLY
Loading...
()
], shows nearly 40 percent of men have never broached the subject with their physician, even though 82 percent of men know ED could be a symptom of serious health problems.
You can read all sorts of other fun factoid findings of the survey here. LLY claims it interviewed the 300 men who are at least 45 years old "to further understand men's current beliefs about ED and DE treatment options, as well as the perceptions men have about communicating with their healthcare professional about ED."
Yeah, uh-huh, sure.
I'm guessin' they knew I couldn't resist blogging about ED.
Lilly has turned Cialis--the pill that lasts in your system for a day-and-a-half--into a blockbuster. And it recently launched a one-a-day version of the drug. Pfizer sold nearly half-a-billion dollars worth of Viagra in the first quarter of this year. GlaxoSmithKline [GSK
Loading...
()
], Schering-Plough [SGP
Loading...
()
] and the German Bayer[BAY
Loading...
()
] share Levitra which is an also-ran, me-too ED drug. But I do know one new Levitra convert. A certain co-worker, who will remain unnamed, recently told me he spent more than 300 bucks to fill a Levitra prescription his neighbor wrote for him. Mr. Anonymous said he'd grown frustrated with his primary care physician who would only write him tiny, apparently insufficient, prescriptions for Viagra.
I also wonder what, if any, impact General Motors' [GM
Loading...
()
]decision to cut healthcare benefits for retirees could have on ED drug sales. Especially if other companies follow GM's lead.
We'll get a read on more recent impotence pill sales when big pharma starts reporting earnings next week.
Questions? Comments?










